Peter P. Lee

Peter P. Lee publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter P. Lee sits on this spectrum.

Peter P. Lee D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter P. Lee sits on this spectrum.

Best Publications

• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

  Peter P. Lee;Cassian Yee;Peter A. Savage;Lawrence Fong

  1388
  Citations

• Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

  Jeffrey J. Molldrem;Peter P. Lee;Changqing Wang;Kyrie Felio

  863
  Citations

• Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

  Kristin Sanderson;Ronald Scotland;Peter Lee;Dongxin Liu

  634
  Citations

• Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

  Cassian Yee;John A. Thompson;Patrick Roche;David R. Byrd

  588
  Citations

• Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

  Cassian Yee;Peter A. Savage;Peter P. Lee;Mark M. Davis

  536
  Citations

• Ex vivo identification, isolation and analysis of tumor-cytolytic T cells

  Valerie Rubio;Tor B. Stuge;Naileshni S Singh;Michael R. Betts

  507
  Citations

• A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

  Helmut Jonuleit;Andrea Giesecke‐Tuettenberg;Thomas Tüting;Beatrice Thurner‐Schuler

  478
  Citations

• Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

  Ulrich Keilholz;Jeffrey Weber;James H. Finke;Dmitry I. Gabrilovich

  384
  Citations

• Impaired interferon signaling is a common immune defect in human cancer

  Rebecca J. Critchley-Thorne;Diana L. Simons;Ning Yan;Andrea K. Miyahira

  349
  Citations

• STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

  Chunyan Zhang;Chanyu Yue;Andreas Herrmann;Jieun Song

  347
  Citations

• Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer

  Holbrook E Kohrt;Navid Nouri;Kent Nowels;Denise Johnson

  298
  Citations

• Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma

  P. Lee;F. Wang;J. Kuniyoshi;V. Rubio

  286
  Citations

• A Phase I Trial of Tumor Lysate-pulsed Dendritic Cells in the Treatment of Advanced Cancer

  Alfred E. Chang;Bruce G. Redman;Joel R. Whitfield;Brian J. Nickoloff

  282
  Citations

• Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

  Theresa L.-Y. Chang;Chia-Hwa Chang;David A. Simpson;Qiang Xu

  272
  Citations

• Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells

  Jeffrey J. Molldrem;Peter P. Lee;Shreya Kant;Eric Wieder

  268
  Citations

• Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.

  Jeffrey Weber M.D.;Vernon K. Sondak;Ronaldo Scotland;Ramila Phillip

  253
  Citations

• A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.

  Jeffrey J. Molldrem;Peter P. Lee;Changqing Wang;Richard E. Champlin

  221
  Citations

• Gene expression network analysis and applications to immunology

  Şerban Nacu;Rebecca Critchley-Thorne;Peter Lee;Susan Holmes

  220
  Citations

• Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

  Rebecca J Critchley-Thorne;Ning Yan;Serban Nacu;Jeffrey Weber

  204
  Citations

• Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death.

  Dobrin Draganov;Sailesh Gopalakrishna-Pillai;Yun-Ru Chen;Neta Zuckerman

  199
  Citations